INTRODUCTION
Heme oxygenase-1, H mox 1, is an inducible cytoprotective enzyme that degrades heme to biliverdin, iron and carbon monoxide, CO (Wu and Wang, 2005) . It is expressed in vascular tissues and is regarded to play an important role in the production of products that have antioxidant and anti-inflammatory activity (Kim et al., 2006; Korthuis and Durante, 2005) . One of the products, CO, has been the focus of many studies that have linked H mox 1 to vascular function.
CO was shown to act as a vasodilator and at high concentrations it stimulated soluble guanylate cyclase (sGC) and cGMP formation (Kim et al., 2006; Durante et al., 2006) . The resultant activation of protein kinase G (GK) led to effective inhibition of smooth muscle contraction through action on myosin phosphatase, K-channels and cellular calcium.
Studies of vascular function have used strategies to stimulate and to inhibit H mox 1 directly and to apply its products such as CO (Kim et al., 2006; Durante et al., 2006) . For instance hemin injected into 8 week old spontaneously hypertensive rats increased H mox 1 and sGC levels in arteries and lowered blood pressure (Ndisang et al.,2002) . Transfection of porcine arteries with H mox 1 shifted the phenylephrine -response curves to the right (reduced sensitivity) while treatment with the H mox inhibitor, ZnPPIX, eliminated the difference (Duckers et al., 2001 ).
Treatment with lipopolysaccharide induced H mox 1 expression in arteries and significantly reduced blood pressure in rats, while pretreatment with ZnPPIX prevented the fall in blood pressure (Yet et al., 1997) .
Metalloprotoporphyrins have been widely used to study the role of H mox in the regulation of vascular function. These compounds, such as ZnPPIX, SnPPIX, and CrMPIX, consistently alter vascular responses in-vitro. For instance ZnPPIX increased myogenic tone in mesenteric arteries from rats exposed to chronic hypoxia, a treatment that increased H mox 1 activity (Naik and Walker, 2006) . A recent study indicated that metalloprotoporphyrins may also have non-specific This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on July 6, 2010 as DOI: 10.1124/jpet.110.169755 at ASPET Journals on July 9, 2017 jpet.aspetjournals.org Downloaded from constrictor effects on rat cerebral arteries (Andresen et al., 2006) . Moreover, these compounds are also effective inhibitors of sGC at concentrations typically used to inhibit H mox (Kim et al., 2006; Stasch et al., 2006) . It should be noted that a reduced heme containing Fe 2+ is necessary for activation of sGC. Inhibition of H mox would remove its anti-oxidant effect, which would lead to increased levels of oxidized (Fe 3+ ) heme and reduced effect of NO (Wu and Wang, 2005) . The interpretation of results derived from the application of an agent that inhibits both H mox and sGC becomes problematic, since these enzymes are closely linked to the signaling pathway operating on smooth muscle contraction
Another approach to the evaluation of H mox 1 has used knock-out mice, H mox 1 -/- (Poss and Tonegawa, 1997) . Although these mice exhibited no change in H mox 2 levels, increased cardiac and renal damage occurred during ischemic conditions (Yet et al., 1999; Wiesel et al., 2001 ). H mox 1 -/-also exhibited an exacerbation of vascular lesions in response to hyperlipidemia, mechanical and photochemical injury (Duckers et al., 2001; True et al., 2007; Yet et al., 2003) . Vascular smooth muscle cells from H mox 1 -/-also exhibited increased proliferation when maintained in cell culture (Duckers et al., 2001) . Surprisingly, we have not found studies that used H mox 1 -/-to evaluate arterial contractile responses and their sensitivity to endothelial and pharmacological relaxants.
The present study was undertaken to determine whether arteries from H mox 1 -/-exhibit functional alterations that are similar to those reported during pharmacological manipulation of H mox activity. In addition, we have attempted to determine whether the nitrate tolerance we observed in arteries from H mox 1 -/-resulted from an altered heme redox-state and/or reduced expression of sGC. Student's t-test was used to test for differences between group means where one treatment was being evaluated and p< 0.05 was taken to be significant. Data are presented as means ± SE.
METHODS

Animals
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RESULTS
Contraction.
The contractile responses of the femoral artery (FA) to 5-HT and the superior mesenteric artery (SMA) to PE were shifted slightly (Δlog = -0.20±0.04), but significantly (p<0.001) to the left in H mox 1 -/-which showed increased sensitivity to the agonists (Fig. 1) . No consistent differences in the maximal contractile response to K80 was observed between the two groups of mice, nor did the ratio of the maximal agonist response to the high K response differ (Table 1 , Supplemental data).
Relaxation. Cumulative increases in Ach elicited a concentration-dependent relaxation of
SMA that was pre-contracted with PE ( Fig The IC 50 for Ach in Fig. 2A was shifted significantly to the right (Δlog = 0.32±0.08, p<0.005)
in the H mox 1 -/-.This shift is more apparent in Fig. 3 where the responses were normalized to the maximal response of each group. A similar shift to the right (Δlog = 0.36 ± 0.11, p<0.01) was also observed in the FA from H mox 1 -/- (Fig. 3) .
Arteries from 5 sites were exposed first to a high concentration (10µM) of an agonist, followed by a high concentration (3µM) of Ach (2-4 minutes) and then SNP (10µM). This protocol was meant to reduce a potential accommodation to Ach and to nitro-compounds which could occur during the extended time (about 20 minutes) used for the cumulative concentrationresponse curves. The percent relaxation to Ach appears in Fig. 4A and to SNP in Fig. 4B . The
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The effectiveness of Ach and the other dilators on H mox 1 -/-was further evaluated in SMA subjected to two levels of agonist stimulation. Stimulation with PE alone resulted in a contraction that was 1.2 times greater than that to K80, whereas added 5-HT resulted in a contraction of over 2.5 times that to K80 in both groups ( Nitrate tolerance. The reduced responses of H mox 1 -/-to Ach and to SNP were similar to responses that occur during nitrate tolerance (Bennett et al., 1988; Friebe and Koesling, 2003) .
Nitrate tolerance can result from multiple causes which include altered redox-state of the heme Fe in sGC and/or down regulation of the amount of sGC expressed in vascular smooth muscle (Friebe and Koesling, 2003; . We adopted a pharmacological approach to the question of altered sGC redox state. The relaxation responses of SMA to an agent (BAY 60-2770) that was reported to be a more effective activator of oxidized/heme-free sGC than reduced/heme-containing sGC were compared to BAY 41-2272 which was a more effective stimulator of reduced sGC (Knorr et al., 2008; Evgenov et al., 2006) . We first tested this concept on SMA from H mox 1 +/+ as shown in heme (Evgenov et al., 2006) . The relaxation to BAY 60-2770 and to BAY 41-2272 exhibited similar sensitivity under control conditions. In the presence of ODQ (~30min pretreatment), the response to BAY 60-2770 was shifted to the left (p<0.01) whereas the response to BAY 41-2272 was shifted to the right (p<0.01) which was similar to the effects reported for other preparations (Knorr et al, 2008; Evgenov et al., 2006) . The IC 50 s shown in Fig. 6 (Fig. 6 ).
Active sGC is a hetero-dimer of one α -subunit and one β -subunit to which the heme associates (Pyriochou and Papapetropoulos, 2005) . Both the α1 and β1 subunit levels in SMA from H mox 1 -/-( Fig 7A) were reduced similarly to 46% and 44% of H mox 1 +/+ (p<0.025). The levels of these subunits in the thoracic aorta (Fig. 7B) were also reduced to 88% and 70% of H mox 1 +/+ (p<0.04). These reductions, however, were significantly less (p<0.001) than the reduction which occurred in the SMA.
DISCUSSION
Our study shows that H mox 1is an important regulator of arterial function. Arteries from H mox 1 -/-exhibited increased sensitivity to constrictors, reduced sensitivity to Ach and greatly reduced relaxation to agents that act via NO and sGC. Reduced relaxation and activity of the GK pathway were previously reported after treatment with metalloprotoporphyrin inhibitors of H mox , but establishing H mox 1 as the primary cause was problematic since sGC could also have been inhibited . Our study avoided this uncertainty.
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Contraction. The increased sensitivity to PE and 5-HT was small and may be secondary to an impaired endothelium. Increased sensitivity to catecholamines occurred after endothelial removal or inhibition of eNOS in normal arteries (Fukuda et al., 1990 , Vanhoutte, 1989 . Thus a normally functioning endothelium has an inhibitory effect through basal production of dilators such as NO. Since H mox 1 -/-exhibited normal blood pressure (Wiesel et al., 2001) , the effect of increased sensitivity to catecholamines appears to be compensated by regulatory mechanisms.
Perturbations (e.g. renal artery clip) that cause hypertension, however, showed an exaggerated response in H mox 1 -/- (Wiesel et al., 2001 ). The enhanced sensitivity of H mox 1 -/-to catecholamines indicates that altered receptor signaling could be a factor. This possibility should be explored.
Relaxation. The small decrease in sensitivity to Ach when coupled with reduced capacity to relax (Fig. 2B ) could also contribute significantly to exaggerated responses to perturbations that cause hypertension. The reduced responses to Ach occurred in multiple sites including small arterial branches (Fig. 4A) . Thus, the dysfunction may extend throughout the vascular system of
The dysfunction in H mox 1 -/-extended to the NO donor, SNP, and to YC-1, a stimulator of sGC (Figs. 2B and 4B). In contrast, Ado, which acts via adenylate cyclase, resulted in equivalent relaxations for both groups. Comparison of the relaxation responses at two levels of contraction (Table 1 , Supplemental data) showed that the dysfunction was more apparent at the greater contraction. This supports the concept that the capacity of sGC is reduced in H mox 1 -/-. At low levels of contraction, sGC had sufficient activity to provide intermediate control, whereas the capacity was insufficient to provide adequate responses at high levels of contraction. This could explain why H mox 1 -/-with normal blood pressure exhibited an exaggerated increase when the system was perturbed with a renal artery clip (Wiesel et al., 2001) (Fig. 6) . This is consistent with the conclusion that a high percentage of sGC in H mox 1 -/-was oxidized/heme-free before treatment with ODQ. The observation that the untreated SMA from H mox 1 -/-was 15 fold more sensitive to BAY 60-2770 also supports this conclusion. This difference was negated by ODQ pretreatment of H mox 1 +/+ .
The H mox 1 -/-did retain an ability to relax to BAY 41-2272 in the absence and presence of ODQ. This is consistent with the observation that BAY 41-2272 (10µM) stimulated sGC about 4
fold in the presence of ODQ (Stasch et al., 2001) . Although this was 10 times less than the stimulation in the absence of ODQ, it could be sufficient for a biological effect. For instance a 3 fold increase in cGMP induced by SNP was associated with 80% relaxation of rat aorta (Magliola and Jones, 1990) . As little as 6% of the sGC content was sufficient to support NO relaxation in aorta from α 1 -sGC deficient mice and the concept was proposed that spare sGC receptors ensure high NO sensitivity (Mergia et al., 2006) . BAY 41-2272 may also have an inhibitory action on phosphodiesterase type 5 (PDE5) yielding a sidenafil-like effect (Mullershausen et al., 2004) . Our protocol for the BAY compounds employed PE contractures which developed half the force achieved with PE plus 5-HT (Table 1 , Supplemental data). Under these conditions sufficient reduced sGC may be available for BAY 41-2272 to relax SMA from
A third factor is an increased degradation of oxidized/heme-free sGC. Both Simultaneous treatment of the preparations with BAY 58-2667 prevented the loss of sGC subunits (Hoffmann et al., 2009 , Meurer et al., 2009 . It was further shown that oxidized/hemefree sGC was selectively targeted for ubiquitination and proteasomal degradation, a process that was inhibited by BAY 58-2667 (Meurer et al., 2009 ). It appears that oxidation of the sGC heme reduces the responses to NO by acute removal of its receptor heme, and by a slower removal of the subunits which contain the catalytic sites. Our observation of a >50% reduction of α 1-and β 1-sGC levels in SMA from H mox 1 -/- (Fig. 7A ) is in the range noted above (Hoffmann et al., 2009 , Meurer et al., 2009 ). This finding supports the concept that sGC in H mox 1 -/-has undergone significant oxidation, heme loss and degradation. At ~50% loss of sGC, we observed significant loss of relaxation in SMA. A lesser reduction in sGC occurred in the aorta (Fig.7B ) which was not associated with a significant change in relaxation (Fig. 4) . Vascular tissues appear to contain spare sGC and a partial loss (12% to 30% ) may not affect relaxation during sub-maximal contraction and exposure to high concentrations of NO. Our observations on SMA from H mox 1 -/-indicate that the loss of anti-oxidant function resulted in an ODQ-like effect on sGC. This supports the proposal that H mox 1 is important for the maintenance of sufficient reduced sGC to meet challenges such as ischemia reperfusion injury.
Anti-oxidant function of H mox 1. H mox 1 is recognized to be part of the cellular anti-oxidant system. Our study identified by means of a H mox 1 knockout model a specific target, sGC, that is maintained in a reduced state as a result of H mox 1. The antioxidant properties of H mox 1 products may be particularly important in preventing oxidation of the vulnerable Fe 2+ in the weakly bonded heme group on sGC. Maintenance of sensitivity to NO, production of cGMP, and activation of GK has been shown to be especially important for the reduction of ischemia reperfusion injury (Ahluwalia et al., 2004) . The sGC pathway is also important for the This article has not been copyedited and formatted. The final version may differ from this version.
at ASPET Journals on July 9, 2017 jpet.aspetjournals.org Downloaded from maintenance of normal cardiovascular function Wolin, 2009) . During the initial stages of reperfusion, the cascade of oxidants that are produced may oxidize the sGC heme causing it to become refractory to the eNOS product, NO, but not to such compounds as BAY 60-2770 and BAY 58-2667. BAY 58-2667 when given 5 minutes before cardiac reperfusion, significantly reduced the infarct size (Krieg et al., 2009) . Therefore strategies which recognize the importance of H mox 1 in maintaining reduced sGC could lead to more effective prevention of tissue injury.
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